Lori Valigra

As part of its recent reorganization, HP is taking Open Innovation to the next level by seeking proposals to fund hot new technologies.

By carefully manipulating materials at the nanoscale, researchers hope to devise more effective and personalised medical diagnostics and therapies.

Corporate incubators bridge the seed funding gap, but apart from pocket money what can start-ups learn from their foster parents?

Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.

The pace of new product introductions picked up in the US in 2006, although the number of start-up companies spun off from research institutions fell, according a new survey.

The art of innovation – putting one’s ideas first, trumpeting your merits, taking on risk – is most “un-Finnish”. But not to one Finn.

Director Leon Sandler talks about how MIT’s Deshpande Center is attracting a combination of entrepreneurs, venture capitalists and managers to jump start new ideas in science and technology.

It's been tough to actually put a price on patents. Will reform of the US patent rules make it easier to capitalise on intellectual property?

Flagship venture capitalist David Berry takes a hands-on approach to finding and nurturing emerging ideas and companies in life sciences and clean energy.

When Lita Nelsen, director of MIT’s technology licensing office, is asked whether MIT has an incubator, she responds, “Yes, it’s called the city of Cambridge.” Lori Valigra looks at how MIT's environment drives entrepreneurship.